1-alkyl-6-oxo-1,6-dihydropyridin-3-yl Compounds as Selective Glucocorticoid Receptor Modulators
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current glucocorticoid therapies for inflammatory and immune conditions are limited by severe side effects, and there is a need for alternative therapies that offer the beneficial effects of glucocorticoids with reduced side effects, improved potency, selectivity, and stability.
Innovation Solution
Development of 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and their pharmaceutical compositions that act as selective glucocorticoid receptor modulators, providing partial agonist and antagonist activity, allowing for effective treatment of conditions like rheumatoid arthritis with reduced side effects and improved pharmacokinetic profiles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If glucocorticoids are used to treat inflammatory and immune conditions, then therapeutic effectiveness is improved, but severe side effects occur
Solution Approach 1:
The patent segments the pharmacological effects of glucocorticoids by developing selective GR modulators that can independently activate beneficial anti-inflammatory pathways while avoiding pathways that lead to side effects. The compounds selectively modulate gene expression and signaling pathways to achieve therapeutic separation of desired effects from harmful effects.
Solution Approach 2:
The patent applies local quality by creating compounds with differentiated receptor interaction properties. The selective GR modulators exhibit different binding characteristics and transcriptional regulatory patterns compared to conventional glucocorticoids, allowing beneficial effects in target tissues while minimizing cross-reactivity with other steroid receptors that cause side effects.
2Reliability
If conventional glucocorticoids are used, then anti-inflammatory effects are achieved, but selectivity for glucocorticoid receptor is reduced due to cross-reactivity with other steroid receptors
Solution Approach 1:
The patent segments receptor interactions by designing compounds that specifically target the glucocorticoid receptor with distinct binding characteristics. The selective modulators exhibit preferential binding to GR compared to other steroid receptors, achieving functional segmentation of receptor engagement to eliminate cross-reactivity while maintaining anti-inflammatory efficacy.
Solution Approach 2:
The patent applies local quality through compounds with differentiated molecular recognition properties. The selective GR modulators possess structural features that confer specificity for glucocorticoid receptor binding, creating localized interaction quality that distinguishes GR from other steroid receptors with homologous ligand binding domains.
3Duration of action of stationary object
If glucocorticoids are administered chronically, then sustained therapeutic benefit is achieved, but cumulative side effects increase
Solution Approach 1:
The patent segments the temporal profile of drug effects by developing selective modulators that maintain sustained therapeutic activity without cumulative toxicity. The compounds achieve prolonged duration of action through selective GR modulation while avoiding the accumulation of harmful effects that occurs with conventional glucocorticoid chronic administration.
Solution Approach 2:
The patent applies continuity of useful action by creating selective GR modulators that provide sustained anti-inflammatory and immunosuppressive effects over time. The compounds maintain continuous therapeutic benefit through stable GR binding and modulation while preventing the cumulative side effect profile associated with long-term conventional glucocorticoid use.
Data Source
AI summary
This specification generally relates to 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds (including salts thereof). This specification also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including treatment methods and medicament preparations), and processes for making such a compound.